ATAI
week primary weeks week primary weeks randomization topline data expected end of randomization topline data expected mid pivotal study single dose pivotal study fixed repeat dose placebo week primary change from in total score at week the participant population definition and core inclusion exclusion criteria remains unchanged compared to phase compass pathways studies are deliver by | ATAI
Company
Deck Type
Sector
Industry
Deck date
October 2022
Slide
21 of 41
Similar slides by ATAI
See diffirences between slides (animation)
Investor Presentation
January 2024
compass pathways is currently conducting a phase pivotal program with topline data expected in summer and mid proceeded by long target | ATAI
Investor Presentation
October 2023
compass pathways is currently conducting a phase pivotal program with topline data expected in summer and mid proceeded by long target | ATAI
Investor Presentation
April 2023
pivotal phase trial designs pivotal study single dose randomization target topline data expected summer pivotal study fixed repeat dose randomization target topline data expected mid compass pathways is currently conducting a program composed of two trials which are to deliver by and | ATAI
Investor Presentation
March 2023
pivotal phase trial designs pivotal study single dose randomization target topline data expected summer pivotal study fixed repeat dose randomization target topline data expected mid compass pathways studies are to deliver by and | ATAI
Related slides by other companies
Ocuphire Pharma
Results
March 2021
primary of subjects study eye returning to at min | Ocuphire Pharma
NeuroSense Therapeutics
Investor Presentation
December 2023
phase study results achieved primary with a safety and tolerability profile comparable to placebo | NeuroSense Therapeutics
Erasca
Investor Presentation
January 2024
pivotal phase and phase trial designs capitalize on promising efficacy signals and support potential successful registration in multiple indications setae dor secondary | Erasca
BioAtla
Investor Presentation
August 2022
phase study design with | BioAtla
Other recent decks by ATAI
See all presentations (13 decks)
Investor Presentation
January 2024
Investor Presentation
October 2023
Investor Conference
May 2023
Investor Presentation
April 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2024 Slidebook.io